Through bioinformatics analysis and experimental confirmation, HERC3 was revealed to be downregulated in CRC tissues compared to adjacent-normal tissues, and HERC3 downregulation showed poor prognostic outcomes including DFS and OS. This evidence concerns the gene HERC3 and colorectal carcinoma.